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Autism spectrum disorders (ASDs) are neuropsychiatric diseases characterized by
impaired social interaction, communication deficits, and repetitive and stereotyped
behaviors. ASD etiology is unknown, and both genetic and environmental causes have
been proposed. Different brain structures are believed to play a role in ASD-related
behaviors, including medial prefrontal cortex (mPFC), hippocampus, piriform cortex
(Pir), basolateral amygdala (BLA) and Cerebellum. Compelling evidence suggests a
link between white matter modifications and ASD symptoms in patients. Besides,
an hypomyelination of the mPFC has been associated in rodents to social behavior
impairment, one of the main symptoms of ASD. However, a comparative analysis of
myelination as well as oligodendroglial (OL)-lineage cells in brain regions associated to
social behaviors in animal models of ASD has not been performed so far. Here, we
investigated whether OL-lineage cells and myelination are altered in a murine model
of ASD induced by the prenatal exposure to valproic acid (VPA). We showed an
hypomyelination in the BLA and Pir of adult VPA-exposed mice. These results were
accompanied by a decrease in the number of OL-lineage cells and of mature OLs in
the Pir, in addition to the mPFC, where myelination presented no alterations. In these
regions the number of oligodendrocyte progenitors (OPCs) remained unaltered. Likewise,
activation of histone deacetylases (HDACs) on OL-lineage cells in adulthood showed no
differences. Overall, our results reveal OL-lineage cell alterations and hypomyelination as
neuropathological hallmarks of ASD that have been overlooked so far.
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INTRODUCTION
Autism spectrum disorders (ASDs) are a group of neurodevelopmental disorders characterized
by impaired social interaction, communication deficits, and repetitive, stereotyped behaviors
(American Psychiatric Association, 2013). These symptoms appear early in life and
persist during adulthood. ASD etiology is unknown, and both genetic and environmental
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factors can contribute to its development (Betancur, 2011).
There are currently no treatments that can treat ASD symptoms
altogether.
There is no current consensus about the underlying
neuropathology in ASD, and different brain structures have been
proposed to play a role in ASD symptoms. In humans, the medial
prefrontal cortex (mPFC) was identified as one of the main brain
areas whose connectivity is affected in ASD subjects (Cheng
et al., 2015), while other areas also exhibit altered neuronal
number or volume in people diagnosed with ASD, e.g., the
basolateral amygdala (BLA; Lin et al., 2013; Wegiel et al., 2014),
the Hippocampus (Sussman et al., 2015) and the cerebellum
(Fatemi et al., 2012; Sussman et al., 2015).
Different animal models for ASD have been validated for
studying the cellular andmolecular alterations that lead to altered
behavior in these disorders. In particular, prenatal exposure to
valproic acid (VPA) results in reduced sociability and increased
repetitive behaviors (Lucchina and Depino, 2014; Campolongo
et al., 2018). In addition, other cellular and molecular alterations
related to ASD are also observed in animals prenatally exposed to
VPA, e.g., neuroinflammation (Lucchina and Depino, 2014), and
altered excitation/inhibition balance (Cunningham et al., 2003).
Finally, this animal model also shows alterations in neuronal
function in a region recently involved in social behaviors, the
Piriform cortex (Pir; Choe et al., 2015; Campolongo et al., 2018).
Increasing evidence links neuropsychiatric conditions with
white matter alterations (Fields, 2008). Concerning ASD, white
matter integrity and myelin thickness was found altered in the
brains of ASD patients, particularly in the inter-hemispheric
circuitry and in the corpus callosum (Travers et al., 2012; Ameis
et al., 2016). Furthermore, a link between myelination of the
mPFC and social exploration deficits has been described in mice
(Liu et al., 2012; Makinodan et al., 2012).
Myelin, a multilamellar structure that ensheathes axons and
allows for fast saltatory conduction of action potentials, is
produced by oligodendrocytes (OLs) both during development
and in adult life in vertebrates. Myelin has been recently shown
to respond to and participate in the activity and fine-tuning
of neuronal networks, which results in the modulation of
speed and synchronicity of action potentials as well as provides
metabolic support to axons (Pajevic et al., 2014; Filley and Fields,
2016). Moreover, oligodendrocyte progenitor cells (OPCs) are
synaptically innervated by neuronal fibers throughout the central
nervous system (Bergles et al., 2000; Fröhlich et al., 2011)
thus constituting a potential mechanism for this bilateral
communication.
Interestingly, de novo myelination continues throughout life
(Bergles and Richardson, 2015), and it can contribute to adult
neural plasticity, as the conduction properties of myelinated
neuronal circuits may undergo important transformations. In
this sense, myelin may play a key role in the neuronal circuit
dysfunctions that occur in neuropsychiatric diseases such as
ASD. However, a comparative analysis of the myelination status
and OL differentiation in brain regions functionally related to
ASD symptoms has not been attempted to date.
Here, we investigated whether myelination and OL-lineage
cells were maintained in VPA-treated mice, a well-characterized
ASD murine model that recapitulates the main aspects of
this condition. Our data show long-term alterations in myelin
content and in myelin-producing cells in the mPFC, BLA
and Pir, three brain regions functionally associated with social
behavior. These changes were not associated to H3 acetylation,
an indicator of active DNA transcription, in adult OL-lineage
population. Overall, these results constitute a fundamental
characterization of myelin integrity in an ASDmodel, suggesting




Outbred CrlFcen:CF1mice were obtained from the animal house
at the Faculty of Exact and Natural Sciences (FCEN), University
of Buenos Aires (UBA, Argentina). Animals were housed on
a 12:12 light:dark cycle and 18–22◦C temperature, with food
and water ad libitum. All animal procedures were performed
according to the regulations for the use of laboratory animals
of the National Institute of Health, Washington DC, USA,
and approved by the Institutional Commission for Care and
Use of Laboratory Animals (CICUAL Protocol No. 6/2, FCEN,
UBA, Argentina). Eight-to-ten week old male mice were mated
with nulliparous age matching female mice. Female mice were
controlled daily for presence of vaginal plugs, and whenever
present this day was considered the embryonic day (E) 0.5.
VPA Prenatal Treatment
On E12.5, pregnant mice were subcutaneously injected with
600 mg/kg of VPA sodium salt (Sigma, St. Louis, MO, USA)
resuspended in saline solution or saline solution alone, and
housed individually. The parturition day was registered as
postnatal day 0 (PD0), and the cage bedding was not changed
during the first postnatal week to avoid nest and maternal
care alterations. We studied five male offspring animals per
group for immunofluorescence and 3–4 male animals per group
for electron microscopy (EM), obtained in two independent
cohorts.
Social Interaction Test
At PD60, animals were evaluated in the social interaction test as
previously described (Depino et al., 2011; Lucchina and Depino,
2014; Campolongo et al., 2018). Briefly, mice were habituated
for 10 min to a 40 × 15 cm black rectangular arena divided in
three interconnected chambers placed under dim light (10 lx). A
clear Plexiglass cylinder (7.5 cm of diameter, with several holes
to allow for auditory, visual, and olfactory investigation) was
placed in each side compartment at the beginning of the test.
Prior to the start of each test, one of the end chambers was
randomly designated as the ‘‘non-social side’’ and the other as the
‘‘social side.’’ Animals were placed in the central compartment
and allowed to explore for 10 min (habituation). Then, an
unfamiliar, young (3 weeks) CF1 male mouse (social stimulus)
was placed in one of the cylinders (social side), and an object
(plastic 3 cm-tall cylinder) was placed in the other cylinder (non-
social side). Social interaction was evaluated during a 10 min
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FIGURE 1 | Myelin content decreases upon valproic acid (VPA) treatment in brain areas linked to social behavior. (A–C) Myelin basic protein (MBP) immunostaining in
saline- and VPA-treated adult mouse brains (representative images) and estimated percentage of positive surface in the following areas: (A) medial prefrontal cortex
(mPFC; mean: saline: 55.01 ± 9.12; VPA: 44.17 ± 7.08; Student’s t-test: t = 1.878, p = 0.054). (B) Basolateral amygdala (BLA; mean: saline: 23.89 ± 6.05; VPA:
16.01 ± 4.11; Student’s t-test: t = 2.211, p = 0.031). (C) Piriform cortex (Pir; mean: saline: 11.60 ± 1.81; VPA: 7.92 ± 1.97; Student’s t-test: t = 2.845, p = 0.015).
∗p < 0.05 (Student’s t-test). Scale bars: 100 µm. N = 4–5 mice/treatment. (A’–C’) Correlation between preference for social stimulus and MBP positive area in
mPFC (A’), BLA (B’) and Pir (C’). Significance: p < 0.05 (Pearson correlation analysis).
period. The time the subject spent sniffing the social stimulus
or the non-social stimulus (with the nose <1 cm distance
to a hole of the cylinder) was recorded manually using the
ANY-maze video-tracking system (Stoelting, IL, USA) by an
experimenter blind to treatments. The entire apparatus was
cleaned with a 20% ethanol solution between tests to eliminate
odors.
The preference for the social stimulus was calculated as the
difference between the time spent in the social side vs. the time
spent in the non-social side.
Tissue Processing
At PD90, mice were deeply anesthetized with 80 mg/kg
ketamine chlorhydrate and 8 mg/kg xylazine. Next, they were
transcardially perfused with heparinized saline followed by
cold 4% paraformaldehyde in 0.1 M phosphate buffer (PB)
of pH 7.2. Brains were removed and postfixed in PFA at
4◦C, then cryopreserved in a 30% sucrose solution in PB
at 4◦C until full immersion was observed. Subsequently,
brains were frozen with isopentane and 30 µm coronal
sections were obtained using a cryostat (Leica Biosystems,
Nussloch, Germany), which were either used immediately for
immunostaining or stored at −20◦C in a cryopreservative
solution.
Immunostaining
Free-floating immunostaining was performed as follows: briefly,
every sixth coronal section was incubated in PB for 15 min.
Sections were then incubated in blocking solution, 4% bovine
serum albumin (BSA) in PB with 0.1% Triton X-100 for 45 min.
Primary antibodies were diluted in the blocking solution and
sections were incubated overnight at 4◦C. On the following day
sections were washed three times with 0.1 M PB and incubated
in secondary antibodies diluted in 0.1 M PB for 2 h in the
dark. Sections were then washed with 0.1 M PB and mounted
in Fluoromount-G (Thermo Fisher Scientific, Waltham, MA,
USA).
The primary antibodies used were anti-MBP; anti-myelin
basic protein (AB980, Millipore, MA, USA), anti-Olig2 (AB9610,
Millipore), anti-NG2 (AB5320, Millipore), anti-CC1 (OP80,
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FIGURE 2 | Myelin thickness is impaired upon VPA treatment in brain areas linked to social behavior. (A,E,I) Representative electron micrographs of transversal
sections from mPFC (A), BLA (E), Pir (I) of saline- and VPA treated animals. Arrowheads in the pictures of saline-treated groups show examples of myelinated (black)
and unmyelinated (white) axons. (B,F,J) Dot plot of the G-ratio distribution along axonal diameters for saline- (gray) and VPA- (black) treated animals at the mPFC (B),
BLA (F) and Pir (J). (C,G,K) Mean G-ratio at the mPFC (C; mean G-ratio: saline: 0.819 ± 0.012; VPA: 0.813 ± 0.001; Student’s t-test: t = 0.497, p = 0.645), BLA
(G; mean G-ratio: saline: 0.819 ± 0.004; VPA: 0.837 ± 0.004; Student’s t-test: t = 2.81, p = 0.0375) and Pir (K; mean G-ratio: saline: 0.809 ± 0.003; VPA:
0.840 ± 0.0105; Student’s t-test: t = 2.8, p = 0.049). (D,H,L) G-ratio values along ranges of axonal diameters at the mPFC [D; means: (0.3–0.5) saline: 0.787
±0.012; VPA: 0.773 ± 0.011; Student’s t-test: t = 1.46, p = 0.109; (0.5–0.7) saline: 0.815 ± 0.011; VPA: 0.814 ±0.005; Student’s t-test: t = 0.234, p = 0.413
(0.7–0.9) saline: 0.843 ± 0.008; VPA: 0.830 ± 0.013; Student’s t-test: t = 1.38, p = 0.0119 (>0.9) saline: 0.870 ± 0.013; VPA: 0.857 ± 0.008; Student’s t-test:
t = 1.40, p = 0.117], BLA [H (0.3–0.5) saline: 0.787 ± 0.016; VPA: 0.809 ± 0.006; Student’s t-test: t = −2.15, p = 0.042 (0.5–0.7) saline: 0.819 ± 0.006; VPA:
0.836 ± 0.001; Student’s t-test: t = −4.27, p = 0.004 (0.7–0.9) saline: 0.832 ±0.013; VPA: 0.851 ± 0.005; Student’s t-test: t = −2.25, p = 0.037 (>0.9) saline:
0.865 ± 0.020; VPA: 0.865 ± 0.018; Student’s t-test: t < 0.001, p = 0.499] and Pir [L (0.3–0.5) saline: 0.786 ± 0.010; VPA: 0.820 ± 0.019; Student’s t-test:
t = −2.73, p = 0.026 (0.5–0.7) saline: 0.809 ± 0.006; VPA: 0.841 ± 0.011; Student’s t-test: t = −4.18, p = 0.007 (0.7–0.9) saline: 0.820 ± 0.009; VPA:
0.854 ± 0.008; Student’s t-test: t = −4.77, p = 0.004 (>0.9) saline: 0.830 ± 0.011; VPA: 0.867 ± 0.022; Student’s t-test: t = −2.47, p = 0.034], ∗∗p < 0.01,
∗p < 0.05 (Student’s t-test). N = 3 mice per condition.
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FIGURE 3 | VPA treatment reduces oligodendroglial (OL)-lineage cell numbers in brain areas linked to social behavior. Olig2 immunostaining in saline- and
VPA-treated adult mouse brains (representative images, left panels) and Olig2-positive cell quantifications (right panels) in the following areas: (A) mPFC (mean:
saline: 284.43 ± 53.29; VPA: 222.29 ± 23.80; Student’s t-test: t = 2.12, p = 0.039); (B) BLA (mean: saline: 260.63 ± 23.58; VPA: 285.50 ± 17.62; Student’s t-test:
t = −1.83, p = 0.052); (C) Pir (mean: saline: 186.69 ± 30.01; VPA: 135.08 ± 42.91; Student’s t-test: t = 2.13, p = 0.035). ∗p < 0.05, Student’s t-test. Scale bars:
100 µm. N = 4–5 mice/treatment.
Millipore), and anti-acetylated histone-3 (anti-AcH3; Santa Cruz
Biotechnology, Dallas, TX, USA). Secondary antibodies used
were Alexa 488 and Alexa 568-conjugated donkey anti-rat,
mouse or rabbit (Jackson Laboratories, West Grove, PA, USA).
For each brain structure of interest, 20–25 z-stack images
were taken 1 µm apart, spanning the entire depth of
the tissue section (30 µm) using a Confocal Olympus
FV1200 microscope with 20× (numerical aperture-NA 0.40)
and 40× (NA 0.65) objectives for BLA/Pir and mPFC
respectively. Images with a resolution of 0.31 (mPFC) and
0.62 microns (BLA and Pir) were analyzed on maximal
projection with NIH ImageJ1 using a macro that allows for
systematically subtracting the same background in all images and




For ultrastructural visualization of myelinated axons in the PFC,
BLA and Pir, PD90 mice were perfused with 1% glutaraldehyde
and 4% paraformaldehyde in PB. Brains were immersed in
the same fixative for 1 h. After rinsing brains with PB,
100-µm sagittal sections spanning the area of interest were
obtained with a vibratome (Leica VT1000S). In order to
standardize the quantifications and due to potential differences
in myelination within each region along the lateral axis, we
chose the exact same sagittal section of each region in all
brains to proceed with. We subsequently incubated them in
2% osmium tetroxide (OsO4) for 1 h, rinsed them in distilled
water and contrasted them with uranyl acetate 5% for 30 min.
Dehydration was achieved by a graded series of ethanol and
clearing in acetone. Sections were then embedded in epoxy
resin (Agar Scientific, UK) and incubated at 56◦C for 48 h
to allow for polymerization. Polymerized Epon blocks were
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FIGURE 4 | VPA treatment reduces mature OL numbers in brain areas linked to social behavior. CC1 immunostaining in saline- and VPA-treated adult mouse brains
(representative images, left panels) and CC1 positive cell quantifications (right panels) in the following areas: (A) mPFC (mean: saline: 53.93 ± 19.22; VPA: 22.77 ± 2,
69; Student’s t-test: t = 3.52, p = 0.006); (B) BLA (mean: saline: 93.79 ± 10.21; VPA: 84.42 ± 12.32; Student’s t-test: t = 1.17, p = 0.143); (C) Pir (mean: saline:
74.31 ± 4.46; VPA: 57.99 ± 6.89; Student’s t-test: t = 3.53, p = 0.008). ∗p < 0.05, ∗∗p < 0.01, Student’s t-test. Scale bars: 100 µm. N = 4–5 mice/treatment.
observed at the dissection microscope and the area of interest
was manually microdissected. Next, dissected blocks were cut
in 1 µm semi-thin sections with an ultramicrotome (UC7,
Leica) which were stained with toluidine blue and visualized
until the entire tissue area was observed. Then, serial ultra-thin
sections (∼70 nm thick) were collected onto copper grids
(about 3–4 sections per grid) and visualized at the transmission
electronic microscope (Hitachi HT7700). Electron micrographs
were taken at ×18,000 magnifications using an integrated AMT
XR41-B camera (2,048 × 2,048 pixels).
Measurements were made using NIH ImageJ. G-ratio was
calculated by dividing the axonal diameter by the total diameter
of the axon including the surrounding myelin sheath. Both
diameters were calculated by averaging two perpendicular
measurements. For each condition, the g-ratio of at least
250 randomly selected axons was calculated.
Statistical Analysis
Sample data were tested for normal distribution. Unpaired and
paired Student’s t-test were used for comparisons. Correlations
were performed and analyzed using the Graphpad Prism
software, where Pearson’s coefficient, R square and p values were
calculated. In all cases, statistical significance was considered
when p < 0.05.
RESULTS
Prenatal VPA Exposure Affects Myelination
in Brain Regions Linked to Social Behavior
Mice prenatally exposed to VPA showed reduced sociability
in adulthood (Supplementary Figure S1). We then aimed to
study whether VPA treated mice presented alterations in myelin
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FIGURE 5 | Histone acetylation in OL-lineage cells is unaltered upon VPA-treatment in brain areas linked to social behavior. Double Olig2/acetylated histone-3
(AcH3) immunostaining in saline- and VPA-treated adult mouse brains (representative images, left panels), and estimated percentage of acetylated histone-3
(AcH3) positive cells among Olig2 positive cells (right panels) in the following areas: (A) mPFC (mean: saline: 57.55 ± 6.76; VPA: 59.78 ± 5.23; Student’s t-test:
t = −0.49, p = 0.321); (B) BLA (mean: saline: 62.40 ± 6.03; VPA: 54.29 ± 14.83; Student’s t-test: t = 1.073, p = 0.162); (C) Pir (mean: saline: 51.71 ± 5.43; VPA:
46.31 ± 7.87; Student’s t-test: t = −1.038, p = 0.173). ∗p < 0.05, Student’s t-test. Scale bars: 100 µm. N = 4–5 mice/treatment.
content in areas related to social behavior. As a first approach,
we performed immunostainings for MBP detection—an essential
protein component of myelin—and quantified the relative
MBP-positive area in the following regions: mPFC, BLA, Pir,
hippocampus and cerebellum. Figure 1 shows the comparisons
between mice prenatally exposed to VPA or saline (control).
Whereas significant differences were observed in the BLA and Pir
(Figures 1B,C) as well as a tendency in the mPFC (Figure 1A),
the hippocampus and lobule VII of the cerebellum presented
an equivalent amount of myelin in both experimental groups
(Supplementary Figures S2A,B). We performed correlations
between the preference for the social stimulus and the MBP
positive area in all animals (Figures 1A’–C’). Whereas in the
mPFC these parameters do not correlate (r = 0.64; R2 = 0.42;
p = 0.084), they do show a significant positive correlation in both
the BLA (r = 0.78; R2 = 0.60; p = 0.014) and the Pir (r = 0.77;
Pir: R2 = 0.59; p = 0.026). These results suggest a link between
the VPA-triggered social deficits and the hypomyelination
observed.
Next, we extended our analyses of the observed
hypomyelination and performed EM in an independent cohort
of animals. For that, we studied at the EM level the areas where a
different amount of myelin content was observed, the mPFC, the
BLA and the Pir, where we quantified the G-ratio as a measure of
myelin sheath thickness (Figures 2A–L). In the mPFC, we found
no differences in the G-ratio distribution along axonal diameters
(Figures 2A,B) or the mean G-ratio (Figures 2A,C). Moreover,
the G-ratio was not affected in any population harboring a
specific range of axonal diameters (Figure 2D). Consistently,
the distribution of axonal diameters was not affected by VPA
treatment (Supplementary Figure S3A). In the BLA, prenatal
VPA treatment affected the mean G-ratio (Figures 2E,G). Here,
the slope of the curve was slightly shifted upwards in the VPA
group where axonal diameters are smaller (Figure 2F). In the
same line, and while axonal diameter distribution was preserved
(Supplementary Figure S3B), the G-ratio was affected in axons
of diameters ranging from 0.3 µm to 0.9 µm but not over
0.9 µm (Figure 2H), indicating that the effect of VPA treatment
in the BLA is extensive but exclusively on fibers with axonal
diameters under 0.9 µm. In the Pir, the mean G-ratio was
affected upon prenatal VPA treatment (Figures 2I,K) and the
distribution curve showed a shift upwards in the VPA group
(Figure 2J). Consistently, the G-ratio was affected in axons of
all sizes (Figure 2L), whereas the axonal diameters themselves
showed no differences in their distribution upon VPA treatment
(Supplementary Figure S3C). Altogether, our data indicate that
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myelination, and G-ratio in particular, is affected in both BLA
and Pir regions of VPA-treated animals.
Prenatal Exposure to VPA Reduces
OL-Lineage Numbers in the mPFC and Pir,
but Not in the BLA
Next, we investigated whether the impaired myelination was
accompanied with a decrease in OL-lineage cells. For that,
we quantified the number of Olig2-positive cells in the
aforementioned regions (Figure 3) of saline- and VPA-treated
mice. We observed that the number of Olig2-positive cells was
lower in two regions of VPA-treatedmice: themPFC (Figure 3A)
that shows equivalent levels of myelination than saline-treated
group; and the Pir which has a reduced myelin content
(Figure 3C). In contrast, in the BLA, where myelination was also
reduced, the OL-lineage cell numbers were similar in both groups
(Figure 3B). These results suggest that different mechanisms
can underlie the lower myelination observed in the Pir and
BLA. In the other regions where myelination was unaltered
upon VPA treatment, the hippocampus and cerebellum,
OL-lineage cell numbers were equivalent in both experimental
groups (Supplementary Figures S4A,B). Hence, a decrease in
myelination can be associated with less oligodendroglial cells
as it occurs in the Pir, although not exclusively, as observed in
the BLA.
Prenatal VPA Exposure Reduces Mature
OL Numbers in the mPFC and Pir, but Not
in the BLA
We next studied whether a specific stage of the OL-lineage cells
was differentially affected in VPA-treated animals. In order to
answer this, we performed immunostainings for CC1 and for
NG2 markers, to identify mature OLs and OPCs respectively.
NG2 cells did not display any difference in number in both the
mPFC and Pir (Supplementary Figures S5A–F), indicating that
OPC numbers in adulthood are not affected by VPA treatment.
However, the number ofmatureOLs did decrease in both of these
regions (Figures 4A,C), whereas in the BLA themature OLs were
not affected (Figure 4B), showing a distribution similar to what
we observed for the whole OL-lineage population.
Histone Acetylation Is Not Affected in
Oligodendroglial Cells in Any of the
Regions Studied
Last, as it has been shown that histone deacetylation is required
for oligodendrocyte differentiation (Shen et al., 2005, 2008; Ye
et al., 2009; Liu et al., 2012), we explored the possibility that
the decrease in myelination was related to persistent epigenetic
changes in OL-lineage cells in VPA-treated mice. We assessed
the proportion of Olig2-positive OL-lineage cells that expressed
AcH3, a marker of histone deacetylase recruitment to promoter
regions. As it can be observed in Figures 5A–C, this proportion
remains unchanged in the regions analyzed, therefore suggesting
that persistent histone deacetylation might not participate in
neither the reduction ofmyelination observed in the BLA and Pir,
nor in the changes in OL-lineage cells and mature OLs observed
in the Pir and mPFC.
DISCUSSION
This work shows that in adult mice prenatally exposed to VPA,
which display the core symptoms of ASD, the myelin content
in some of the main brain regions linked to social behavior
(BLA and Pir) is diminished.Moreover, the deficit inmyelination
in the BLA and Pir regions correlates with levels of sociability
observed in these mice, with VPA treated animals showing less
sociability and having less MBP levels. EM studies confirm these
myelin alterations by showing a thinnermyelin sheath (measured
as G-ratio) in axons of the BLA and Pir regions in VPA-treated
mice. This impairment can be accompanied by a reduction in
OL-lineage cells and of mature OLs, or can occur without any
perturbation in the number of myelin-producing cells, found in
the Pir and BLA regions respectively. Similarly, the OL-lineage
cell and mature OL reduction can be reduced in response to
VPA treatment without a concomitant decrease in myelin, as it
is observed in the mPFC. In addition, in the hippocampus and
cerebellum no differences were observed in myelin content nor
in OL-lineage cell number upon VPA-treatment. This suggests
that in the VPA-treated group, either closely related or different
mechanisms may participate in myelination impairment and
OL-lineage cell reduction depending on the region analyzed.
Finally, histone acetylation in OL-lineage cells is not affected by
VPA treatment, therefore it does not account for the observed
effects in myelination and/or OL-lineage cell reduction.
A lower myelination has been described in some of the
regions studied here in different mouse models that recapitulate
ASD-core symptoms. Particularly, in a mouse model of fragile
X syndrome, the cerebellum displays a transient reduction in
MBP and 2’,3’-cyclic nucleotide 3’-phosphodiesterase (CNP)
expression as well as myelination at PD7, later showing complete
recovery at PD15 (Pacey et al., 2013). In addition, myelination
did also show alterations in the cerebellum of Slc25a12-knockout
mice at PD35 (Sakurai et al., 2010). As these studies analyze
myelination during development, we cannot rule out a potential
transient decrease of myelin in this region at younger stages in
VPA-treated animals. Concerning the hippocampus, a decrease
in MBP expression has been reported in VPA-exposed rats
at PD35, along with fewer OL-lineage cells specifically in
CA1 and CA2 areas (Cartocci et al., 2018). We consider that
the differences in species and ages analyzed may account for
the discrepancies between that study and the results presented
here. Lastly, a functional link between myelination of the mPFC
and social behaviors have been shown (Sirevaag and Greenough,
1987; Sánchez et al., 1998; Liu et al., 2012; Makinodan et al.,
2012).
Similarly, vast evidence shows a link between ASD symptoms
and alterations in white matter in ASD patients. For example,
decreased myelin thickness in the orbitofrontal cortex—a
subregion of the PFC in humans- has been reported in post
mortem tissue of ASD patients (Zikopoulos and Barbas, 2010).
The fractional anisotropy values (a measure of white matter
integrity) were also shown altered in the BLA of ASD patients
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(Barnea-Goraly et al., 2004), whereas in the Pir the extent of
myelination and white matter integrity have not been analyzed
in the context of ASD patients, although this region has been
associated with social behavior (Richter et al., 2005; Borelli
et al., 2009; Campolongo et al., 2018). Overall, these studies
reinforce the concept that impairment of myelin development
and disruption of white matter tracts in regions implicated in
social functioning may contribute to impaired social cognition
in ASD.
We observed that in one of the regions analyzed, the Pir,
myelin reduction is accompanied with a decrease in mature OL
number, whereas OPCs are maintained. This suggests that in this
region, reduced myelination may likely result from a failure in
the OPC differentiation towards mature OLs. On the contrary,
in the BLA, myelin reduction was observed concurrently with
an equivalent number of OL-lineage cells and mature OLs.
Here, other mechanisms related to the myelination process itself
might play a central role in this outcome. It is possible that
in this case, defects in the myelination process per se were
playing a role, regulated by key transducers such as the myelin
regulatory factor (MRF), a critical regulator of myelination
whose downregulation does not affect differentiation intomature
OLs (Emery et al., 2009). Other factors with a similar specific
role in myelination are ZFP191 (Howng et al., 2010), Nkx6.2,
essential for paranode structure (Southwood et al., 2004),
and ErBb3 signaling, which recapitulates the social isolation
effects on impaired myelination due to myelinating OL altered
morphology (Makinodan et al., 2012). Conversely, we describe
that prenatal VPA treatment did not affect myelination in the
mPFC, although it caused a reduction in the OL-lineage cells
and particularly in the mature-OLs. This phenomenon can be
linked to CNP protein function, which is essential for axonal
survival but not for myelin assembly. In the absence of this
protein, mice developed axonal loss as a consequence of OL
dysfunctions; however, the content, ultrastructure and physical
properties of myelin are not altered in young mice (Lappe-
Siefke et al., 2003). Therefore, as OLs are an essential component
for axonal survival, the possibility that OL impaired functions
were sufficient for affecting neuronal communication and circuit
integrity without altering myelination should also be taken into
account.
Another important aspect that should also be considered in
order to better understand the differences described here is the
fact that OLs are indeed heterogeneous among brain regions
in terms of transcriptomic profiles as well as timing of OL
maturation and migration (Zhang et al., 2014; Marques et al.,
2016). Different subsets of OLs throughout the brain are just
beginning to be characterized, thus this information will be
valuable to explain different OL involvement in pathological
conditions.
Given that the core behaviors of ASD that are recapitulated in
the VPA model are generated by neuronal circuit dysfunctions,
and that neuronal activity is now known to play a critical
role in myelination (Wake et al., 2011; Gibson et al., 2014;
Mensch et al., 2015), we cannot rule out the possibility that
altered neuronal activity with subsequent social impairment
and lower myelination were not just causally related, but that
these concomitant modifications were a result of a distorted
bidirectional communication. In this sense, the same study that
described an impaired myelination in mice that were exposed
to a social isolation paradigm, reported that the OL-specific
knock out of Neuregulin-ErbB3 signaling, a key pathway for
myelination, results in social deficits and defective myelination
(Makinodan et al., 2012). Demyelination of the mPFC by
cuprizone treatment also resulted in diminished social behavior
(Makinodan et al., 2009). Therefore, studies that shed light
on the communication between these two processes in the
context of VPA treatment, and particularly on whether neuronal
activity is involved in the uncoupling of OL axonal support
and myelination, would be a valuable step towards a deeper
understanding of the reported effects.
We speculated with the hypothesis that epigenetic
modifications within the OL-lineage cells might account
for the myelination defects in VPA-treated mice. In this
sense, it has been shown that in demyelinating conditions,
recruitment of histone deacetylases (HDACs) to promoter
regions of myelin genes precedes myelin synthesis. As the
brain ages, this recruitment becomes more inefficient, thus
allowing transcriptional inhibition and in turn preventing
myelin gene expression (Liu et al., 2012). The presence of
HDACs in the OL cell nuclei is therefore an early indicator of
myelin synthesis. VPA is known to have an inhibitory effect on
HDACs (Göttlicher et al., 2001).We aimed to determine whether
in this model myelination impairment was associated with a
difference in the degree of histone acetylation as a consequence
of a poor myelin turnover. However, we observed no differences
in AcH3 expression in OL-lineage cells between control and
VPA groups. This suggests that adult myelin plasticity in
response to VPA treatment might not be mediated by changes
in nuclear heterochromatin. Nevertheless, we cannot rule out
that histone acetylation occurs in earlier stages of development
in VPA-treated mice and that they can lead to the reduction in
myelin that we observe.
Overall, our results using prenatal VPA treatment establish
a fundamental cellular link between two processes that are
just beginning to be considered as functionally related. We
describe a deficit in myelination in some of the main regions
involved in social behavior in an animal model of ASD, which
shows key features of this psychiatric disorder. We show
that myelin reduction can be unrelated to alterations in the
number of OL-lineage cells and of mature OLs, suggesting
that depending on the brain region analyzed, different
mechanisms mediate this response. While the present approach
is robust and non-invasive due to its prenatal characteristics,
exploring our hypotheses in different environmental and
genetic ASD models would be necessary to confirm the
translational implications of our results and to understand
additional signatures regarding the correlation between
decreased myelination and ASD core symptoms. Thus, our
work opens new basic questions that may guide us to a
better understanding of the link between OL axonal support,
myelination and ASD related behaviors, and that can eventually
lead to novel targets for therapeutic interventions in individuals
affected by ASD.
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